Friday, November 11, 2005

First-Time Generic Approvals: Amaryl, Norvasc, Altace

Via Medscape:
The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for the management of diabetes mellitus; amlodipine besylate 2.5-, 5-, and 10-mg [base] tablets for the treatment of hypertension and coronary artery disease; and ramipril 1.25-, 2.5-, 5-, and 10-mg capsules for the treatment of hypertension and reduction of cardiovascular risk.
Technorati Tags: Amaryl, Norvasc, Altace

1 comment:

Anonymous said...

This is great news for the patients and not so great news for Pfizer and Wyeth/Monarch/King pharmaceuticals.

My vets will have an easier time with me getting these agents to them without prostrating myself before the gatekeeper pharmacists.